RM Global Health

www.rmgh.net

 
  • Increase font size
  • Default font size
  • Decrease font size
  • default color
  • green color
  • blue color

Baxter Healthcare Corp. and FDA notified healthcare professionals

E-mail Print PDF
{mosimage}FDA - MedWatch - Baxter Healthcare Corp. and FDA notified healthcare professionals and consumers of a Class I Recall of Baxter Upgraded COLLEAGUE Triple Channel Volumetric Infusion Pumps, Model numbers 2M8153, 2M8163, and 2M9163.
MedWatch - The FDA Safety Information and Adverse Event Reporting Program

These electronic infusion pumps are used to deliver controlled amounts of medications or other fluids to patients through an intravenous (IV), intra-arterial (IA), epidural, or other direct line into the bloodstream.

The product was recalled because a software irregularity causes the newly upgraded COLLEAGUE Triple Channel Volumetric Infusion Pumps to alarm, display an error code (16:310:867:0002) and stop the infusion. This occurs during user programming with all three channels infusing fluids at the same time. There are reports of serious injuries that are associated with this issue. In reported cases, the pump stopped infusing which caused it to activate an audible and a visual alarm. Interruption of life-sustaining therapy could lead to serious injury or death. Remove all the affected triple channel pumps from service immediately.

COLLEAGUE customers with questions should contact Baxter Medical >Delivery Services at 1-800-843-7867.
Last Updated ( Monday, 11 February 2008 19:56 )  

West Nile virus is a significant health threat. Transmitted by mosquitoes, its symptoms include     headaches, fever, fatigue and muscle aches. Most people recover, but the disease can be fatal. No   vaccine exists. but there are steps you can take to protect yourself, when travel.
 
1. Wear Long Sleeve Shirts and Pants Outdoors
2. Use Mosquito Repellents Containing DEET

3. Secure Window and Door Screens


Alerts

 
Byetta Linked to Acute Pancreatitis Six new cases of hemorrhagic or necrotizing pancreatitis have been reported in patients using exenatide injection (Byett...
 
Why Should I Report an Adverse Drug Event? When I was in charge of the postmarketing drug safety program at the US Food and Drug Administration (FDA) in the early ...